Metabolic effects of prolactin and the role of dopamine agonists: A review

Metabolic effects of prolactin and the role of dopamine agonists: A review

Prolactin is a polypeptide hormone that is well known for its role in reproductive physiology. Recent studies highlight its role in neurohormonal appetite regulation and metabolism. Elevated prolactin levels are widely associated with worsening metabolic disease, but it appears that low prolactin le...

Full description

Bibliographic Details
Main Authors:	Polly Kirsch, Jessica Kunadia, Shruti Shah, Nidhi Agrawal
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Endocrinology
Subjects:	prolactin hyperprolactinemia prolactinoma metabolic syndrome pituitary metabolic dysfunction
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.1002320/full

Similar Items

Diagnostic criteria of small sellar lesions with hyperprolactinemia: Prolactinoma or else
by: Anna Cho, et al.
Published: (2022-09-01)

The frequency of metabolic syndrome and its individual components in women aged 25–45 years, depending on the level of prolactin
by: O. D. Rymar, et al.
Published: (2021-07-01)

Hyperprolactinemia
by: Abha Majumdar, et al.
Published: (2013-01-01)

Interpretation of the 2022 ICCE/AME Position Statement for Clinical Practice in Pituitary Prolactinoma: Update on Clinical Characteristics and Points of Diagnosis and Treatment of Pituitary Prolactinoma
by: TAN Huiwen, LI Danting, YU Yerong
Published: (2024-02-01)

Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients
by: Miriam da Costa OLIVEIRA, et al.
Published: (2020-01-01)

Metabolic association of serum prolactin in polycystic ovary syndrome: A retrospective analysis of 840 patients in Bangladesh
by: A.B.M. Kamrul-Hasan, et al.
Published: (2024-03-01)

Prognostic factors for surgical treatment of prolactin-secreting pituitary adenomas
by: Oleksandr Voznyak, et al.
Published: (2024-02-01)

ASSOCIATION OF ATHEROSCLEROSIS-ASSOCIATED CARDIOVASCULAR RISK FACTORS AT DIFFERENT LEVELS OF PROLACTIN IN WOMEN OF REPRODUCTIVE AGE
by: S. M. Voevoda, et al.
Published: (2018-12-01)

A clinical case of effective treatment of giant prolactinoma in patient with morbid obesity
Published: (2014-06-01)

Comparative efficacy and safety of generic (Bergolak) vs. brand cabergoline in the treatment of patients with prolactin-secreting tumors
by: Galina Afanas'evna Melnichenko, et al.
Published: (2015-04-01)

Description of clinical portraits of patients with hyperprolactinemia
by: Larisa K. Dzeranova, et al.
Published: (2018-10-01)

Hyperprolactinemia associated to calcification of the pituitary stalk: case report
by: OLIVEIRA MIRIAM DA COSTA, et al.
Published: (1998-01-01)

Clinical characteristics and presence of prolactinoma in women with hyperprolactinemia
by: López-Clavijo, Carlos Alberto, et al.
Published: (2016-07-01)

Prolactin Relationship with Fertility and In Vitro Fertilization Outcomes—A Review of the Literature
by: Mirela E. Iancu, et al.
Published: (2023-01-01)

Editorial: Towards targeting prolactin signaling in human diseases: stimulate or inhibit?
by: Vincent Goffin, et al.
Published: (2023-06-01)

Macroprolactinoma resistente aos agonistas dopaminérgicos: relato de caso Macroprolactinoma resistant to dopamine agonists: a case report
by: Rosana Maria dos Reis, et al.
Published: (2004-09-01)

Clinical guidelines ‘Hyperprolactinemia’ (draft)
by: I. I. Dedov, et al.
Published: (2023-07-01)

Management of hyperprolactinemic infertility
by: P.G. Crosignani
Published: (2012-06-01)

Glucose Abnormalities Associated to Prolactin Secreting Pituitary Adenomas
by: Renata S. Auriemma, et al.
Published: (2019-05-01)

Predictors of dopamine agonist resistance in prolactinoma patients
by: Elle Vermeulen, et al.
Published: (2020-05-01)

Metabolic effects of prolactin
by: Rosa Pirchio, et al.
Published: (2022-09-01)

Detection of macroprolactinemia and molecular characterization of prolactin isoforms in blood samples of hyperprolactinemic women
by: Rajinder Chawla, et al.
Published: (2012-01-01)

Increased Lipid Levels Improves after Treatment with Cabergolin in Patients with Prolactinoma
by: Mazhar Muslum Tuna, et al.
Published: (2015-03-01)

Prolactinoma outcome after pregnancy and lactation: A cohort study
by: Bashir A Laway, et al.
Published: (2021-01-01)

Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
by: Youngki Lee, et al.
Published: (2014-09-01)

Contemporary approaches to the diagnosis of hyperprolactinemia
by: О. А. Бурка, et al.
Published: (2019-12-01)

Metabolic and inflammatory parameters in relation to baseline characterization and treatment outcome in patients with prolactinoma: insights from a retrospective cohort study at a single tertiary center
by: Susanna Hofbauer, et al.
Published: (2024-04-01)

Serum prolactin overestimation and risk of misdiagnosis
by: Sunita M.C. De Sousa, et al.
Published: (2019-07-01)

Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms
by: Claudia Pivonello, et al.
Published: (2022-01-01)

Controversial issues in the management of hyperprolactinemia and prolactinomas – An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism
by: Lucio Vilar, et al.

Thyroid autoimmunity and subclinical hypothyroidism in prolactinoma: A case control study
by: Bashir A Laway, et al.
Published: (2023-01-01)

Metabolic effects of dopamine agonists in patients with prolactinomas: a systematic review and meta-analysis
by: Sarah Byberg, et al.
Published: (2019-10-01)

Neuropsychiatric and metabolic aspects of dopaminergic therapy: perspectives from an endocrinologist and a psychiatrist
by: Anastasia P Athanasoulia-Kaspar, et al.
Published: (2018-02-01)

Hyperprolactinaemia – a problem in patients from the reproductive period to the menopause
by: Sylwia Pałubska, et al.
Published: (2017-04-01)

The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology
by: Renata S. Auriemma, et al.
Published: (2020-10-01)

Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy
by: Linjie Wang, et al.
Published: (2023-11-01)

Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
by: Rosa Pirchio, et al.
Published: (2021-11-01)

Changes in serum prolactin level during intracytoplasmic sperm injection, and effect on clinical pregnancy rate: a prospective observational study
by: Ahmed Kamel, et al.
Published: (2018-05-01)

Commentary: Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy
by: Lukas Andereggen, et al.
Published: (2024-03-01)

Multiple cell types in the oviduct express the prolactin receptor
by: Kelly C. Radecki, et al.
Published: (2022-07-01)